The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis

References

• Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685–1699. doi:10.1016/S0140-6736(17)30933-9
   PubMed Web of Science ®Google Scholar
• Pagkopoulou E, Arvanitaki A, Daoussis D, Garyfallos A, Kitas G, Dimitroulas T. Comorbidity burden in systemic sclerosis: beyond disease-specific complications. Rheum Int. 2019;39(9):1507–1517. doi:10.1007/s00296-019-04371-z
   PubMed Web of Science ®Google Scholar
• Kowal-Bielecka O, Fransen J, Avouac J, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76(8):1327–1339. doi:10.1136/annrheumdis-2016-209909
   PubMed Web of Science ®Google Scholar
• Campochiaro C, Allanore Y. An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years. Arthritis Res Ther. 2021;23(1). doi:10.1186/s13075-021-02536-5
   PubMed Web of Science ®Google Scholar
• Vliet Vlieland TPM. Multidisciplinary team care and outcomes in rheumatoid arthritis. Curr Opin Rheumatol. 2004;16(2):153–156. doi:10.1097/00002281-200403000-00015
   PubMed Web of Science ®Google Scholar
• Nakayama A, Tunnicliffe DJ, Thakkar V, et al. Patients’ perspectives and experiences living with systemic sclerosis: a systematic review and thematic synthesis of qualitative studies. J Rheumatol. 2016;43(7):1363–1375. doi:10.3899/jrheum.151309
   PubMed Web of Science ®Google Scholar
• Denton CP, Laird B, Moros L, Luis J, Flores L. Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals-a discourse analysis. Clin Rheum. 2021;40(4):1399–1407. doi:10.1007/s10067-020-05371-2
   PubMed Web of Science ®Google Scholar
• Psarras A, Soulaidopoulos S, Garyfallos A, Kitas G, Dimitroulas T. A critical view on cardiovascular risk in systemic sclerosis. Rheumatol Int. 2017;37(1):85–95. doi:10.1007/s00296-016-3530-3
   PubMed Web of Science ®Google Scholar
• Tyndall AJ, Bannert B, Vonk M, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR scleroderma trials and research (EUSTAR) database. Ann Rheum Dis. 2010;69(10):1809–1815. doi:10.1136/ard.2009.114264
   PubMed Web of Science ®Google Scholar
• Desai CS, Lee DC, Shah SJ. Systemic sclerosis and the heart: current diagnosis and management. Curr Opin Rheumatol. 2011;23(6):545. doi:10.1097/BOR.0b013e32834b8975
   PubMed Web of Science ®Google Scholar
• Mavrogeni SI, Schwitter J, Gargani L, et al. Cardiovascular magnetic resonance in systemic sclerosis: “Pearls and pitfalls.”. Semin Arthritis Rheum. 2017;47(1):79–85. doi:10.1016/j.semarthrit.2017.03.020
   PubMed Web of Science ®Google Scholar
• Seferovic PM, Ristic AD. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology. 2006;45(suppl_4):iv39–iv42. doi:10.1093/rheumatology/kel315
   PubMed Web of Science ®Google Scholar
• Thenappan T, Ormiston ML, Ryan JJ, Archer SL. State of the art review: pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360:j5492.
   PubMed Web of Science ®Google Scholar
• Hettema ME, Bootsma H, Kallenberg CGM. Macrovascular disease and atherosclerosis in SSc. Rheumatology. 2008;47(5):578–583. doi:10.1093/rheumatology/ken078
   PubMed Web of Science ®Google Scholar
• Fernández Morales A, Iniesta N, Fernández-Codina A, et al. Cardiac tamponade and severe pericardial effusion in systemic sclerosis: report of nine patients and review of the literature. Int J Rheum Dis. 2017;20(10):1582–1592. doi:10.1111/1756-185X.12952
   PubMed Web of Science ®Google Scholar
• Bissell LA, Anderson M, Burgess M, et al. Consensus best practice pathway of the UK systemic sclerosis study group: management of cardiac disease in systemic sclerosis. Rheumatology. 2017;56(6):912–921. doi:10.1093/rheumatology/kew488
   PubMed Web of Science ®Google Scholar
• Ross L, Moxey J, Nikpour M. Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review. Semin Arthritis Rheum. 2021;51(1):299–309. doi:10.1016/j.semarthrit.2020.10.016
   PubMed Web of Science ®Google Scholar
• Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119. doi:10.1093/eurheartj/ehv317
   PubMed Web of Science ®Google Scholar
• Campochiaro C, de Luca G, Farina N, et al. Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis. Scand J Rheumatol. 2022;51(2):156–158. doi:10.1080/03009742.2021.1932582
   PubMed Web of Science ®Google Scholar
• Spinella A, Coppi F, Mattioli AV, et al. Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal. J Cardiovasc Med. 2018;19(9):513–515. doi:10.2459/JCM.0000000000000693
   Google Scholar
• van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747–1755. doi:10.1136/annrheumdis-2013-204424
   PubMed Web of Science ®Google Scholar
• Young A, Moles VM, Jaafar S, et al. Performance of the DETECT algorithm for pulmonary hypertension screening in a systemic sclerosis cohort. Arthritis Rheuma. 2021;73(9):1731–1737. doi:10.1002/art.41732
   PubMed Web of Science ®Google Scholar
• Launay D, Sobanski V, Hachulla E, Humbert M. Pulmonary hypertension in systemic sclerosis: different phenotypes. Eur Respir Rev. 2017;26(145):145. doi:10.1183/16000617.0056-2017
   Web of Science ®Google Scholar
• Mcgoon MD, Benza RL, Escribano-Subias P, et al. Pulmonary arterial hypertension epidemiology and registries. J Am Coll Cardiol. 2013;62(25):D51–D59. doi:10.1016/j.jacc.2013.10.023
   PubMed Web of Science ®Google Scholar
• Hoffmann-Vold AM, Allanore Y, Alves M, et al. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Ann Rheum Dis. 2021;80(2):219–227. doi:10.1136/annrheumdis-2020-217455
   PubMed Web of Science ®Google Scholar
• Sobanski V, Launay D, Hachulla E, Humbert M. Current approaches to the treatment of systemic-sclerosis-associated pulmonary arterial hypertension (SSc-PAH). Curr Rheumatol Rep. 2016;18(2):1–14. doi:10.1007/s11926-015-0560-x
   PubMed Web of Science ®Google Scholar
• Gargani L, Voilliot D, D’Alto M, et al. Pulmonary circulation on the crossroads between the left and right heart in systemic sclerosis: a clinical challenge for cardiologists and rheumatologists. Heart Fail Clin. 2018;14(3):271–281. doi:10.1016/j.hfc.2018.02.004
   PubMed Web of Science ®Google Scholar
• Xu SL, Yang J, Zhang CF, et al. Serum cardiac troponin elevation predicts mortality in patients with pulmonary hypertension: a meta-analysis of eight cohort studies. Clin Respir J. 2019;13(2):82–91. doi:10.1111/crj.12991
   PubMed Web of Science ®Google Scholar
• Savale L, Akagi S, Tu L, et al. Serum and pulmonary uric acid in pulmonary arterial hypertension. Eur Respir J. 2021;58(2):2000332. doi:10.1183/13993003.00332-2020
   PubMed Web of Science ®Google Scholar
• Mathai SC, Danoff SK. Management of interstitial lung disease associated with connective tissue disease. BMJ. 2016;352. doi:10.1136/bmj.h6819
   PubMed Web of Science ®Google Scholar
• George PM, Wells AU. Disease staging and sub setting of interstitial lung disease associated with systemic sclerosis: impact on therapy. Expert Rev Clin Immunol. 2018;14(2):127–135. doi:10.1080/1744666X.2018.1427064
   PubMed Web of Science ®Google Scholar
• Wells AU, Margaritopoulos GA, Antoniou KM, Denton C. Interstitial lung disease in systemic sclerosis. Semin Respir Crit Care Med. 2014;35(2):213–221. doi:10.1055/s-0034-1371541
   PubMed Web of Science ®Google Scholar
• Silver RM, Wells AU. Histopathology and bronchoalveolar lavage. Rheumatology. 2008;47(Suppl 5):v62. doi:10.1093/rheumatology/ken272
   PubMed Web of Science ®Google Scholar
• Roofeh D, Jaafar S, Vummidi D, Khanna D. Management of systemic sclerosis-associated interstitial lung disease. Curr Opin Rheumatol. 2019;31(3):241. doi:10.1097/BOR.0000000000000592
   PubMed Web of Science ®Google Scholar
• Cottin V, Brown KK. Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respir Res. 2019;20(1). doi:10.1186/s12931-019-0980-7
   PubMed Web of Science ®Google Scholar
• Hoffmann-Vold AM, Maher TM, Philpot EE, et al. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. Lancet Rheum. 2020;2(2):e71–e83. doi:10.1016/S2665-9913(19)30144-4
   Google Scholar
• Suliman YA, Dobrota R, Huscher D, et al. Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheuma. 2015;67(12):3256–3261. doi:10.1002/art.39405
   PubMed Web of Science ®Google Scholar
• Hoffmann-Vold AM, Allanore Y, Bendstrup E, et al. The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease. Respir Res. 2020;21(1). doi:10.1186/s12931-020-01459-0
   PubMed Web of Science ®Google Scholar
• Frauenfelder T, Winklehner A, Nguyen TDL, et al. Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study. Ann Rheum Dis. 2014;73(12):2069–2073. doi:10.1136/annrheumdis-2014-205637
   PubMed Web of Science ®Google Scholar
• Winklehner A, Berger N, Maurer B, Distler O, Alkadhi H, Frauenfelder T. Screening for interstitial lung disease in systemic sclerosis: the diagnostic accuracy of HRCT image series with high increment and reduced number of slices. Ann Rheum Dis. 2012;71(4):549–552. doi:10.1136/annrheumdis-2011-200564
   PubMed Web of Science ®Google Scholar
• Schmeiser T, Saar P, Jin D, et al. Profile of gastrointestinal involvement in patients with systemic sclerosis. Rheumatol Int. 2012;32(8):2471–2478. doi:10.1007/s00296-011-1988-6
   PubMed Web of Science ®Google Scholar
• Sallam H, McNearney TA, Chen JDZ. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther. 2006;23(6):691–712. doi:10.1111/j.1365-2036.2006.02804.x
   PubMed Web of Science ®Google Scholar
• Alantar A, Cabane J, Hachulla E, et al. Recommendations for the care of oral involvement in patients with systemic sclerosis. Arthritis Care Res. 2011;63(8):1126–1133. doi:10.1002/acr.20480
   Web of Science ®Google Scholar
• Harrison E, Herrick AL, Mclaughlin JT, Lal S. Review malnutrition in systemic sclerosis. Rheumatology. 2012;51(10):1747–1756. doi:10.1093/rheumatology/kes160
   PubMed Web of Science ®Google Scholar
• Doerfler B, Allen TS, Southwood C, Brenner D, Hirano I, Sheean P. Medical nutrition therapy for patients with advanced systemic sclerosis (MNT PASS): a pilot intervention study. J Parenter Enter Nutr. 2017;41(4):678–684. doi:10.1177/0148607115597883
   PubMed Web of Science ®Google Scholar
• Sakkas LI, Simopoulou T, Daoussis D, Liossis SN, Potamianos S. Intestinal involvement in systemic sclerosis: a clinical review. Dig Dis Sci. 2018;63(4):834–844. doi:10.1007/s10620-018-4977-8
   PubMed Web of Science ®Google Scholar
• Patti MG, Vela MF, Odell DD, Richter JE, Fisichella PM, Vaezi MF. The intersection of GERD, aspiration, and lung transplantation. J Laparoendosc Adv Surg Tech. 2016;26(7):501–505. doi:10.1089/lap.2016.0170
   PubMed Web of Science ®Google Scholar
• Host LV, Campochiaro C, Afonso A, Nihtyanova SI, Denton CP, Ong VH. High proton pump inhibitor exposure increases risk of calcinosis in systemic sclerosis. Rheumatology. 2021;60(2):849–854. doi:10.1093/rheumatology/keaa332
   PubMed Web of Science ®Google Scholar
• Schouffoer AA, Ninaber MK, Beaart-van De Voorde LJJ, et al. Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis. Arthritis Care Res. 2011;63(6):909–917. doi:10.1002/acr.20448
   PubMed Web of Science ®Google Scholar
• Virzì F, Bianca P, Giammona A, et al. Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients. Stem Cell Res Ther. 2017;8(1). doi:10.1186/s13287-017-0690-3
   PubMed Web of Science ®Google Scholar
• Sandler RD, Matucci-Cerinic M, Hughes M. Musculoskeletal hand involvement in systemic sclerosis. Semin Arthritis Rheum. 2020;50(2):329–334. doi:10.1016/j.semarthrit.2019.11.003
   PubMed Web of Science ®Google Scholar
• Doré A, Lucas M, Ivanco D, Medsger TA, Domsic RT. Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis. Arthritis Care Res. 2013;65(8):1385–1389. doi:10.1002/acr.21964
   PubMed Web of Science ®Google Scholar
• Devogelaer JP, Huaux JP, Maldague B, Malghem J, Noël H, de Deuxchaisnes CN. Intra-articular calcification in progressive systemic sclerosis. Clin Rheumatol. 1986;5(2):262–267. doi:10.1007/BF02032367
   PubMed Web of Science ®Google Scholar
• Ranque B, Authier FJ, Le-guern V, et al. A descriptive and prognostic study of systemic sclerosis-associated myopathies. Ann Rheum Dis. 2009;68(9):1474–1477. doi:10.1136/ard.2008.095919
   PubMed Web of Science ®Google Scholar
• Varjú C, Pethö E, Kutas R, Czirják L. The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis. Clin Rehabil. 2003;17(1):83–87. doi:10.1191/0269215503cr572oa
   PubMed Web of Science ®Google Scholar
• Paik JJ, Wigley FM, Shah AA, et al. Association of fibrosing myopathy in systemic sclerosis and higher mortality. Arthritis Care Res. 2017;69(11):1764–1770. doi:10.1002/acr.23291
   Web of Science ®Google Scholar
• Impens AJ, Rothman J, Schiopu E, et al. Sexual activity and functioning in female scleroderma patients. Clin Exp Rheumatol. 2009;27(3 Suppl):54.
   PubMed Web of Science ®Google Scholar
• Munira S, Christopher-Stine L. Pregnancy in myositis and scleroderma. Best Pract Res Clin Obstet Gynaecol. 2019;64:59–67.
   PubMed Web of Science ®Google Scholar
• Skorpen CG, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75(5):795–810. doi:10.1136/annrheumdis-2015-208840
   PubMed Web of Science ®Google Scholar
• Clark KEN, Etomi O, Ong VH. Systemic sclerosis in pregnancy. Obstetric Med. 2020;13(3):105–111. doi:10.1177/1753495X19878042
   PubMed Web of Science ®Google Scholar
• Miniati I, Guiducci S, Mecacci F, Mello G, Matucci-Cerinic M. Pregnancy in systemic sclerosis. Rheumatology. 2008;47(Suppl 3):iii16–iii18. doi:10.1093/rheumatology/ken174
   PubMed Web of Science ®Google Scholar
• Bonifazi M, Tramacere I, Pomponio G, et al. Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies. Rheumatology. 2013;52(1):143–154. doi:10.1093/rheumatology/kes303
   PubMed Web of Science ®Google Scholar
• Bielefeld P, Meyer P, Caillot D, et al. [Systemic scleroderma and cancers: 21 cases and review of the literature]. La Revue de Med Interne. 1996;17(10):810–813. French. doi:10.1016/0248-8663(96)82683-X
   PubMed Web of Science ®Google Scholar
• Shah AA, Rosen A, Hummers L, Wigley F, Casciola-Rosen L. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies. Arthritis Rheum. 2010;62(9):2787–2795. doi:10.1002/art.27549
   PubMed Web of Science ®Google Scholar
• Lazzaroni MG, Campochiaro C, Bertoldo E, et al. Association of anti-RNA polymerase III antibody with silicone breast implants rupture in a multicentre series of Italian patients with systemic sclerosis. Clin Exp Rheumatol. 2021;39(4):25–28. doi:10.55563/clinexprheumatol/mg0paj
   PubMed Web of Science ®Google Scholar
• Joseph CG, Darrah E, Shah AA, et al. Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science. 2014;343(6167):152–157. doi:10.1126/science.1246886
   PubMed Web of Science ®Google Scholar
• Terrier B, Humbert S, Preta LH, et al. Risk of scleroderma according to the type of immune checkpoint inhibitors. Autoimmun Rev. 2020;19(8):102596. doi:10.1016/j.autrev.2020.102596
   PubMed Web of Science ®Google Scholar
• Cavalli G, Farina N, Campochiaro C, et al. Repurposing of biologic and targeted synthetic anti-rheumatic drugs in COVID-19 and hyper-inflammation: a comprehensive review of available and emerging evidence at the peak of the pandemic. Front Pharmacol. 2020;11. doi:10.3389/fphar.2020.598308
   PubMed Web of Science ®Google Scholar
• Thombs BD, Taillefer SS, Hudson M, Baron M. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum. 2007;57(6):1089–1097. doi:10.1002/art.22910
   PubMed Web of Science ®Google Scholar
• Frech T, Hays RD, Maranian P, Clements PJ, Furst DE, Khanna D. Prevalence and correlates of sleep disturbance in systemic sclerosis–results from the UCLA scleroderma quality of life study. Rheumatology. 2011;50(7):1280–1287. doi:10.1093/rheumatology/ker020
   PubMed Web of Science ®Google Scholar
• Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology. 2011;50(4):762–767. doi:10.1093/rheumatology/keq310
   PubMed Web of Science ®Google Scholar
• Malcarne VL, Fox RS, Mills SD, Gholizadeh S. Psychosocial aspects of systemic sclerosis. Curr Opin Rheumatol. 2013;25(6):707–713. doi:10.1097/01.bor.0000434666.47397.c2
   PubMed Web of Science ®Google Scholar
• Mozzetta A, Antinone V, Alfani S, et al. Mental health in patients with systemic sclerosis: a controlled investigation. J Eur Acad Dermatol Venereol. 2008;22(3):336–340. doi:10.1111/j.1468-3083.2007.02426.x
   PubMed Web of Science ®Google Scholar
• Kwakkenbos L, Bluyssen SJM, Vonk MC, et al. Addressing patient health care demands in systemic sclerosis: pre-post assessment of a psycho-educational group programme. Clin Exp Rheumatol. 2011;29(2 Suppl):65.
   PubMed Web of Science ®Google Scholar
• Farina N, Ramirez GA, de Lorenzo R, et al. COVID-19: pharmacology and kinetics of viral clearance. Pharmacol Res. 2020;161:105114.
   PubMed Web of Science ®Google Scholar
• Denton CP, Campochiaro C, Bruni C, Distler O, Iagnocco A, Matucci Cerinic M. COVID-19 and systemic sclerosis: rising to the challenge of a pandemic. J Scleroderma Relat Disord. 2021;6(1):58–65. doi:10.1177/2397198320963393
   PubMed Web of Science ®Google Scholar
• Ferri C, Giuggioli D, Raimondo V, et al. Covid-19 and rheumatic autoimmune systemic diseases: role of pre-existing lung involvement and ongoing treatments. Curr Pharm Des. 2021;27(41):4245–4252. doi:10.2174/1381612827666210903103935
   PubMed Web of Science ®Google Scholar
• Orlandi M, Landini N, Sambataro G, et al. The role of chest ct in deciphering interstitial lung involvement: systemic sclerosis versus covid-19. Rheumatology. 2021. doi:10.1093/rheumatology/keab801
   Web of Science ®Google Scholar
• Avouac J, Airó P, Carlier N, Matucci-Cerinic M, Allanore Y. Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab. Ann Rheum Dis. 2020;80(3):e37.
   PubMed Web of Science ®Google Scholar
• Campochiaro C, Trignani G, Tomelleri A, Cascinu S, Dagna L. Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey. Ann Rheum Dis. 2021;80(6):816–817. doi:10.1136/annrheumdis-2020-219811
   PubMed Web of Science ®Google Scholar